States See Some U.S. Role Over Pharmacies After Outbreak

State regulators say U.S. health officials need a role in overseeing so-called compounding pharmacies following the meningitis outbreak that killed 39 people this year.

Health officials from the states and Food and Drug Administration met today to discuss whether the federal agency should take more responsibility when compounding pharmacies go beyond the traditional role of preparing personalized prescriptions. The states typically oversee these pharmacies while the FDA regulates drug manufacturing.